Detailed Program
Please note - Information listed in the Detailed Agenda is subject to changes and continually being updated to reflect the most up to date information.
All times listed in Eastern Daylight Time (EDT).
3:00 p.m. - 6:30 p.m. |
Registration |
|
7:00 a.m. - 7:15 p.m. |
Registration |
|
8:30 a.m. - 12:00 p.m. |
VARIOUS ROOMS |
|
1:15 p.m. - 4:30 p.m. |
VARIOUS ROOMS |
|
5:00 p.m. - 5:20 p.m. |
Presidential Address |
Salon E-F |
5:25 p.m. - 6:00 p.m. |
March of Dimes Developmental Biology Prize Presentation and Lecture Susan Fisher, PhD The March of Dimes and Richard B. Johnston, Jr., MD Prize in Developmental Biology honors an outstanding scientist who has profoundly advanced the science that underlies our understanding of pregnancy, parturition and prenatal development. The Prize is sponsored by the Society for Reproductive Investigation, whose mission to advance reproductive and women’s health care through outstanding basic, translational and clinical science and by training and mentoring future generations of investigators complements March of Dimes’ work to support healthy moms and strong babies. The recipients of the Prize are leaders in reproductive biology working on translational and actionable science that can develop into interventions or preventions that will improve the health of moms and babies everywhere. |
Salon E-F |
6:00 p.m. - 7:00 p.m. |
President's New Investigator Plenary |
Salon E-F |
7:00 p.m. - 7:30 p.m |
Awards Ceremony |
Salon E-F |
7:30 p.m. - 8:30 p.m. |
Welcome Reception |
3rd Floor Atrium |
7:00 a.m. - 6:00 p.m. |
Registration |
|||
8:00 a.m. - 10:00 a.m. |
Concurrent Oral Presentations I |
|
||
Clinical and Translational Perinatology I |
Salon AB |
|||
8:00 a.m. - 8:15 a.m. |
O-005: Molecular Mechanisms Underlying Selective Sorting of MiRNAs into Small Extracellular Vesicles in Placental Cells in Gestational Diabetes Mellitus (GDM) |
|
||
8:15 a.m. - 8:30 a.m. |
|
|
||
8:30 a.m. - 8:45 a.m. |
O-007: Metabolomic Signatures of Low and High Adiposity Neonates Differ Based on Maternal BMI |
|
||
8:45 a.m. - 9:00 a.m. |
O-008: Adult Offspring of Obese Mice Have Reduced Resistance Artery Vasodilator Responses |
|
||
9:00 a.m. - 9:15 a.m. |
O-009: The Impact of Pre-Pregnancy Maternal Lipid Metabolism on Neonatal Adiposity |
|
||
9:15 a.m. - 9:30 a.m. |
O-010: Highly Atherogenic Lipid Particles Are Associated with Preeclampsia (Pre-E) in Obese Women with Unexplained Infertility Who Conceived during Ovarian Stimulation with Intrauterine Insemination (OS-IUI) |
|
||
9:30 a.m. - 9:45 a.m. |
O-011: Frequency and Correlates of Severe Chronic Hypertension (CHTN) 5 - 7 Years after Pregnancy Complicated by Mild CHTN |
|
||
9:45 a.m. - 10:00 a.m. |
O-012: A Prognostic Model for Early Risk Stratification of Spontaneous Preterm Birth |
|
||
Gynecology I |
Salon CD |
|||
8:00 a.m. - 8:15 a.m. |
O-013: Loss of MIG-6 Results in Endometrial Progesterone Resistance and Endometriosis-Related Infertility through ERBB2 Overexpression |
|||
8:15 a.m. - 8:30 a.m. |
O-014: The Role of ARID1a in Mediating Endometriosis Disease Progression |
|||
8:30 a.m. - 8:45 a.m. |
O-015: Endometriosis Is a Possible Risk Factor for Premature Cardiovascular Disease |
|||
8:45 a.m. - 9:00 a.m. |
O-016: Randomized, Placebo-Controlled Trial of Botulinum Toxin for Endometriosis-Associated Chronic Pelvic Pain: A Longitudinal Assessment |
|||
9:00 a.m. - 9:15 a.m. |
O-017: Bleeding Patterns in Women with Endometriosis-Associated Pain Treated with Relugolix Combination Therapy: SPIRIT Program |
|||
9:15 a.m. - 9:30 a.m. |
O-018: Single-Cell Sequencing Reveals Novel Cell Type and Heterogeneous Non-Monoclonal Cell Populations in Human Leiomyomas |
|||
9:30 a.m. - 9:45 a.m. |
O-019: Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas via Sponging MiR-29 Family |
|||
9:45 a.m. - 10:00 a.m. |
O-020: Reduction in Menstrual Blood Loss in Patients Treated with Relugolix Combination Therapy: LIBERTY Long-Term Extension Study |
|||
Parturition I |
Salon HI |
|||
8:00 a.m. - 8:15 a.m. |
O-021: Upregulation of miR-877-3p and Downregulation of miR-186-3p in the Placentas of Patients with Idiopathic Preterm Birth |
|||
8:15 a.m. - 8:30 a.m. |
O-022: Iron-Dependent Apoptosis Causes Embryotoxicity in Inflamed and Obese Pregnancy |
|||
8:30 a.m. - 8:45 a.m. |
O-023: A Broad Spectrum Chemokine Inhibitor Prevents Infection-Induced Myometrial Inflammation and Activation |
|||
8:45 a.m. - 9:00 a.m. |
O-024: Exposure to Experimental Fetal Inflammatory Response Syndrome Results in IL-6 Dependent Upregulation of Interferon Lambda Expression and Subsequent Loss of Neonatal Paneth Cells |
|||
9:00 a.m. - 9:15 a.m. |
O-025: Establishment of a Mouse Uterine Explant Model to Study Inflammation in Pregnancy and Parturition |
|||
9:15 a.m. - 9:30 a.m. |
O-026: Inflammatory-Related Mir-612 Is Increased in Circulating Exosome-Like Vesicles from Women Undergoing Preterm Birth |
|||
9:30 a.m. - 9:45 a.m. |
O-027: Dose-Response Profile of a Novel Anti-Interleukin-1 Therapeutic, Rytvela, for Prevention of Preterm Birth |
|||
9:45 a.m. - 10:00 a.m. |
O-028: Placenta Serum Amyloid A-2 (SAA-2) Plays an Important Role in Maternal Inflammation-Induced Adverse Fetal Outcomes |
|||
Placenta I |
Salon KJ |
|||
8:00 a.m. - 8:15 a.m. |
O-029: A Microphysiological Model of Human Trophoblast Invasion during Early Embryo Implantation |
|||
8:15 a.m. - 8:30 a.m. |
O-030: The Utero-Placental Vascular Skeleton: A New Image Processing Technique to Estimate Utero-Placental Vascular Morphologic Development and the Association with Maternal Hemodynamic Adaptation to Pregnancy |
|||
8:30 a.m. - 8:45 a.m. |
O-031: Placental Cell-Specific Extracellular Vesicle Profiles from Syncytiotrophoblasts and Extravillous Trophoblasts in the First Trimester |
|||
8:45 a.m. - 9:00 a.m. |
O-032: Impaired Cell Polarity and Bi-Directional Endothelial Cell-Matrix Interactions Mediate Disrupted Fetoplacental Angiogenesis |
|||
9:00 a.m. - 9:15 a.m. |
O-033: Activation of Amnion Signaling during Intrauterine Inflammation Is TNF-Dependent |
|||
9:15 a.m. - 9:30 a.m. |
O-034: Role of GATA2 and GATA3 in Syncytiotrophoblast Development during Mammalian Placentation |
|||
9:30 a.m. - 9:45 a.m. |
O-035: Females Are Not Just ‘Protected’ Males: Sex-Specific Vulnerabilities in Placenta and Brain after Prenatal Immune Disruption |
|||
9:45 a.m. - 10:00 a.m. |
O-036: Derivation of Human Trophoblast Stem Cells from Pluripotent Stem Cells to Model Early Placental Development |
|||
Maternal Biology and Health |
Wellesley |
|||
8:00 a.m. - 8:15 a.m. |
O-037: Percutaneous Electrical Stimulation of Skeletal Muscle Attenuates Insulin Resistance in Pregnant Rats with Diet-Induced Obesity |
|||
8:15 a.m. - 8:30 a.m. |
O-038: Seasonality and the Immune System during Pregnancy: Impact of Seasonal Affective Disorder |
|||
8:30 a.m. - 8:45 a.m. |
O-039: Estradiol Stimulates Pregnancy-Dependent H2S Biosynthesis in Human Uterine Artery Endothelial Cells via ERα/ERβ-Mediated Upregulation of CBS Transcription |
|||
8:45 a.m. - 9:00 a.m. |
O-040: Placental MiRNAs Predicted to Target Insulin Signaling Pathways Are Associated with Maternal Insulin Resistance in Late Pregnancy |
|||
9:00 a.m. - 9:15 a.m. |
O-041: Clot Formation Potential in the Late Pregnant and Postpartum Woman |
|||
9:15 a.m. - 9:30 a.m. |
O-042: Identification and Isolation of Rare Microchimeric Cells in Maternal and Cord Blood. |
|||
9:30 a.m. - 9:45 a.m. |
O-043: Women with Adverse Pregnancy Outcomes Have Higher Risk of Midlife Stroke: The PATH Study. |
|||
9:45 a.m. - 10:00 a.m. |
O-044: Isolating Mechanisms on Future Cardio-Renal Risk in Mothers with Complicated Pregnancy |
|||
Reproductive Biology I |
Suffolk |
|||
8:00 a.m. - 8:15 a.m. |
O-163: Plasma Enriched in Stem Cell Secreted Factors Improves Ovarian Function in a Mouse Model of Advanced Maternal Aged. |
|||
8:15 a.m. - 8:30 a.m. |
O-046: Screening Putative Haplo-Essential Translation Genes for Contribution to Early Reproductive Failure |
|||
8:30 a.m. - 8:45 a.m. |
O-047: Elucidating the Role of FOXO3 in Regulating Ovarian Reserve and Function in Humans |
|||
8:45 a.m. - 9:00 a.m. |
O-048: Loss of Ovarian Expression of the Noncoding RNA H19 Promotes Susceptibility to Doxorubicin-Induced DNA Damage |
|||
9:00 a.m. - 9:15 a.m. |
O-049: Novel Anti-Mullerian Hormone Receptor 2 Binding Peptide (AMHR2BP) Modulates Oocyte Function In Vivo |
|||
9:15 a.m. - 9:30 a.m. |
O-050: Aneuploidy in Human Embryos May Elicit a Premature Differentiation Response in the Inner Cell Mass |
|||
9:30 a.m. - 9:45 a.m. |
O-051: Bromodomain Extraterminal (BET) Family Inhibitor JQ1 Inhibits Nuclear Maturation and Cytoplasmic Organization of Oocytes |
|||
9:45 a.m. - 10:00 a.m. |
O-052: Opposite Effects of LH/PKA/MTOR and AMPK Signaling on Induction of Autophagy in Luteal Cells |
|||
10:00 a.m. - 10:30 a.m. |
Coffee Break |
Level 3 Foyer & Level 4 Grand Ballroom Foyer |
||
10:30 a.m. - 12:30 p.m. |
Mini-Symposia I |
|
||
Stem Cell Therapy of Reproductive Disorders |
Salon AB |
|||
10:30 a.m. - 10:55 a.m. |
Opportunities and Challenges in Regenerative Therapies |
|||
10:55 a.m. - 11:20 a.m. |
Stem Cell and Gene Therapy of Ovarian Infertility: from Bench to Rodents to Women, and Back |
|||
11:20 a.m. - 11:45 a.m. |
Cell Therapy of Asherman Syndrome and Endometrial Atrophy |
|||
11:45 a.m. - 12:10 p.m. |
Stem cell therapies for male infertility: ready for the clinic |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
|
Pregnancy – A Lost Opportunity to Screen |
Salon CD |
||
10:30 a.m. - 10:55 a.m. |
Pregnancy Complications and the Life Course – Implications for the Child |
|||
10:55 a.m. - 11:20 a.m. |
Placental Insufficiency and Impact on Fetal Development |
|||
11:20 a.m. - 11:45 a.m. |
Adverse Pregnancy Outcomes Screening and Long Term Maternal Health |
|||
11:45 a.m. - 12:10 p.m. |
Patient-Reported Outcomes and the Feasibility of Tracking Long-Term Cardiovascular Disease Outcomes – The Preeclampsia Foundation Registry |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
SRI – PRS Joint Session: Interaction at the Maternal-Fetal Interface and Origins of Child Health and Disease Moderators: Maide Ozen, MD Yoel Sadovsky, MD |
Salon HI |
|||
10:30 a.m. - 10:55 a.m. |
Implications of Immunoperinatology Research on Neonatal and Lifetime Health |
|||
10:55 a.m. - 11:20 a.m. |
Multidisciplinary, Multiplatform Approaches to Unravel the Mechanisms of Adverse Pregnancy Outcomes |
|||
11:20 a.m. - 11:45 a.m. |
Next Frontiers in Vesicle-Based Placental-Maternal-Fetal Communication |
|||
11:45 a.m. - 12:10 p.m. |
Gaps in Knowledge in Understanding the Immunobiology and Immunopathology of Pregnancy and Future Directions |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
Embryo Aneuploidy and Mosaicism: Implications for Reproduction and ART Moderators: Robert N. Taylor, MD, PhD Mindy S. Christianson, MD |
Salon KJ |
|||
10:30 a.m. - 10:55 a.m. |
Understanding Aneuploidy |
|||
10:55 a.m. - 11:20 a.m. |
Developmental Potential of Aneuploid Human Embryos Beyond Implantation |
|||
11:20 a.m. - 11:45 a.m. |
Assessment of Aneuploidy and Mosacisim in Human Embryos: Promises and Pitfalls of Molecular Approaches and Study Designs |
|||
11:45 a.m. - 12:10 p.m. |
New Insights From Clinical NIPT Data Regarding Human Aneuploidy and Mosaicism |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
Translational Research: Diagnostic Innovations in Reproduction Moderators: Erica Marsh, MD, MSCI, FACOG Patricia Jimenez, MD |
Wellesley |
|||
10:30 a.m. - 10:55 a.m. |
Endometriosis Biomarkers |
|||
10:55 a.m. - 11:20 a.m. |
Discovery of Extracellular RNA Biomarkers for Prediction of Preeclampsia |
|||
11:20 a.m. - 11:45 a.m. |
Selecting the most viable embryo: Towards Non-Invasive Technologies |
|||
11:45 a.m. - 12:10 p.m. |
Novel Mechanisms and Potential Targets in Preterm Labor and Birth |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
Reproduction Meets Imaging Moderators: Hari Eswaran, PhD Jessica Ramella-Roman, PhD |
Suffolk |
|||
10:30 a.m. - 10:55 a.m. |
In Vivo Imaging of Reproductive Dynamics in the Mouse Oviduct |
|||
10:55 a.m. - 11:20 a.m. |
Active Fluctuations Modulate Nuclear Dynamics in Oocytes |
|||
11:20 a.m. - 11:45 a.m. |
Quantitative Ultrasound of the Cervix in Pregnancy: Today & Tomorrow |
|||
11:45 a.m. - 12:10 p.m. |
Preventing Postpartum Depression: An Intergenerational fMRI Clinical Trial |
|||
12:10 p.m. - 12:30 p.m. |
Session Q&A |
|||
12:45 p.m. - 1:45 p.m. |
Lunch and Learn Symposium I |
|
||
Big Data and the Impact on Scientific Success |
Salon AB |
|||
12:45 p.m. - 1:00 p.m. |
Introduction to Big Data Analysis |
|||
1:00 p.m. - 1:15 p.m. |
Multi-Omics Approach in Uterine Fibroids Research |
|||
1:15 p.m. - 1:30 p.m. |
Systems Biology Study to Puzzle out Preterm Birth with an Integrated-Omics Approach |
|||
1:30 p.m. - 1:45 p.m. |
Session Q&A |
|||
12:45p.m. - 1:45 p.m. |
Lunch and Learn Symposium II |
|
||
NIH and Reproductive Medicine |
Salon CD |
|||
12:45 p.m. - 1:00 p.m. |
NICHD Strategic Planning Update |
|||
1:00 p.m. - 1:15 p.m. |
Strategies for Obtaining NIH Extramural Funding |
|||
1:15 p.m. - 1:30 p.m. |
Life as an Intramural NIH Researcher |
|||
1:30 p.m. - 1:45 p.m. |
Session Q&A |
|||
2:00 p.m. - 3:30 p.m. |
Concurrent Oral Presentations II |
|
||
Developmental Programming I |
Salon AB |
|||
2:00 p.m. - 2:15 p.m. |
O-053: Epigenetic Effects of N-acetylcysteine on H2S-Mediated Protection Against Fetal Origins of Vascular Disease. |
|||
2:15 p.m. - 2:30 p.m. |
O-054: Placental Endocrine Malfunction Causes Sex Specific Changes in Metabolic Organs of Fetal and Adult Mouse Offspring |
|||
2:30 p.m. - 2:45 p.m. |
O-055: Maternal Obesity Upregulates Fetal Heart Pparg Expression with Consequences for Later Life Cardiac Metabolic and Contractile Function in Mice |
|||
2:45 p.m. - 3:00 p.m. |
O-056: Defining the Role of the Hypothalamic Pituitary Adrenal Axis in the Relationship between Fetal Growth and Adult Cardiometabolic Outcomes |
|||
3:00 p.m. - 3:15 p.m. |
O-155: Zika Virus Vertical Transmission Dynamics in the |
|||
3:15 p.m. - 3:30 p.m. |
O-156: Tracking Postnatal Behavioral Outcomes in a Novel Mouse Model of |
|||
Fetus I |
Salon CD |
|||
2:00 p.m. - 2:15 p.m. |
O-057: Hypoxemia Prevents Insulin Mediated Suppression of Gluconeogenic Gene Expression in the Fetal Liver during Hypoglycemia |
|||
2:15 p.m. - 2:30 p.m. |
O-058: Maternal Obesity Induces Fetal Sheep Hepatic Oxidative Stress (OS) and Mitochondrial Damage Predominantly in the Right Lobe |
|||
2:30 p.m. - 2:45 p.m. |
O-059: Impaired Autonomic Control of Heart Rate Variability during Acute Stress in the Chronically Hypoxic Fetus |
|||
2:45 p.m. - 3:00 p.m. |
O-060: RNAseq of Amniotic Fluid Reveals Activation of the Innate Immune Response and Differential Expression of Brain Transcripts in Fetuses with Cytomegalovirus Infection |
|||
3:00 p.m. - 3:15 p.m. |
O-061: Uterine Fibroids Associated with Lower Fetal Fraction and Indeterminate NIPS Results in Non-Obese Subjects |
|||
3:15 p.m. - 3:30 p.m. |
O-062: Cervical Gene Delivery of the Antimicrobial Peptide Human β Defensin 3 (HBD3) Reduces Perinatal Neuroinflammation in a Mouse Model of Ascending Infection-Associated Preterm Birth |
|||
Preeclampsia I |
Salon HI |
|||
2:00 p.m. - 2:15 p.m. |
O-063: Functional Enrichment Analysis of Differentially Expressed Transcripts/Genes of Medium/Large STBEVs Identified Potentially Dysregulated Pathways in Early Onset Preeclampsia (EOPE) |
|||
2:15 p.m. - 2:30 p.m. |
O-064: Proinflammatory and Anti-Inflammatory Cytokine Responses by Decidua T Cells in Preeclampsia |
|||
2:30 p.m. - 2:45 p.m. |
O-065: Impact of Preeclampsia on Polarization and Functionality of Hofbauer Cells |
|||
2:45 p.m. - 3:00 p.m. |
O-066: CD4 T Cells Deficiency Enhances Internal Carotid Artery Constriction in Postpartum Mice: The Role of Nitric Oxide |
|||
3:00 p.m. - 3:15 p.m. |
O-067: Noninvasive Prediction of Preeclampsia in Pregnancy with Circulating RNA |
|||
3:15 p.m. - 3:30 p.m. |
O-068: Circulating SIGLEC6 Is Deranged in Preeclampsia and May Be a Biomarker of Disease Severity |
|||
Gynecology II |
Salon KJ |
|||
2:00 p.m. - 2:15 p.m. |
O-069: Pregnancy Outcomes Following Routine Early Provision of IUD after First Trimester Induced Abortion - 5-year Follow-Up of a Randomized Controlled Trial |
|||
2:15 p.m. - 2:30 p.m. |
O-070: Towards 3-D Imaging of the Murine Vagina |
|||
2:30 p.m. - 2:45 p.m. |
Withdrew 07.01.2021 |
|||
2:45 p.m. - 3:00 p.m. |
O-072: Euploid Miscarriage Is Associated with Lactobacillus spp. Deplete Vaginal Microbial Composition and Local Inflammation |
|||
3:00 p.m. - 3:15 p.m. |
O-073: Anemia and Abnormal Uterine Bleeding Prevalence in the Environment, Leiomyomas, Latina and Adiposity Study (ELLAS) |
|||
3:15 p.m. - 3:30 p.m. |
O-074: Route of Myomectomy and Probability of Pregnancy or Live Birth |
|||
Parturition II |
Wellesley |
|||
2:00 p.m. - 2:15 p.m. |
O-075: Cell Free Fetal DNA (cffDNA) from Human Amnion Epithelial Cells Increase Inflammatory Load in Human Fetal Membrane Tissue |
|||
2:15 p.m. - 2:30 p.m. |
O-076: Microbial Metabolites Compromise Epithelial Barrier Integrity: Potential Mechanisms by Which Non-Optimal Cervicovaginal Microbiota Lead to Preterm Birth |
|||
2:30 p.m. - 2:45 p.m. |
O-077: Single Cell Transcriptomics Identify Distinct Epithelial Populations in Early versus Late Pregnancy |
|||
2:45 p.m. - 3:00 p.m. |
O-078: Essential Roles of Uterine Peristalsis by Cav1.2 in Reproduction and Adenomyosis in Mice |
|||
3:00 p.m. - 3:15 p.m. |
O-079: Differential Regulation of SOX Family Transcription Factors in the Pregnant and Labouring Mouse Myometrium |
|||
3:15 p.m. - 3:30 p.m. |
O-080: Intrauterine Infection Induced Preterm Labor Is Associated with Site-Specific Phosphorylation of Progesterone Receptor A in Myometrial Cells |
|||
Reproductive Endocrinology and Infertility I |
Suffolk |
|||
2:00 p.m. - 2:15 p.m. |
O-081: Cumulus Cells Transcriptomic Biomarkers of Euploid Human Embryo Implantation |
|||
2:15 p.m. - 2:30 p.m. |
O-082: Rapid Aneuploidy Testing in Reproduction Using Nanopore-Based Sequencing |
|||
2:30 p.m. - 2:45 p.m. |
O-083: Characterization of the Non-Classic Progesterone Receptor Membrane Component 2 (PGRMC2) during the Human Menstrual Cycle and In Vitro Decidualization |
|||
2:45 p.m. - 3:00 p.m. |
O-084: Human Placenta Mesenchymal Stem Cells Derived Exosomes Successfully Reverse Infertility in Chemotherapy Induced Premature Ovarian Insufficiency Mouse Model |
|||
3:00 p.m. - 3:15 p.m. |
O-085: An In Vivo Model of Human FSH Dysregulation in Obesity: Obese Women Exhibit Lower Serum FSH Levels in Response to Intravenous Recombinant FSH after GnRH Suppression |
|||
3:15 p.m. - 3:30 p.m. |
O-086: Different Immunoregulatory Components at the Decidua Basalis of Oocyte Donation Pregnancies |
|||
3:30 p.m. - 4:00 p.m. |
Coffee Break |
Level 3 Foyer & Level 4 Grand Ballroom Foyer |
||
4:00 p.m. - 5:30 p.m. |
Poster Session I |
Back Bay Conference and Exhibition Center |
||
5:45 p.m. - 6:30 p.m. |
President's Distinguished Researchers Award I |
Salon E-F |
||
Joan Steitz, PhD |
||||
6:30 p.m. - 7:10 p.m. |
Awards Ceremony |
Salon E-F |
||
|
||||
|
||||
7:30 p.m. - 9:00 p.m. |
Connection Corners |
3rd Floor Atrium |
7:00 a.m. - 7:00 p.m. |
Registration |
|
||
7:00 a.m. - 8:00 a.m. |
SRI Business Meeting |
Salon E-F |
||
8:00 a.m. - 9:00 a.m. |
President's Distinguished Researchers Award II |
Salon E-F |
||
Gregg L. Semenza, MD, PhD |
||||
9:00 a.m. - 9:45 a.m. |
Hot Topics & Awards Ceremony |
Salon E-F |
||
9:00 a.m. - 9:15 a.m. |
O-153: Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response |
|||
9:15 a.m. - 9:30 a.m. |
O-154: Complement Blockade with Eculizumab for Treatment of Pregnant or Postpartum Women with Severe Coronavirus Disease 2019 |
|||
9:30 a.m. - 9:45 a.m. |
Awards Ceremony
|
|||
9:45 a.m. - 10:15 a.m. |
Coffee Break |
Level 3 Foyer & Level 4 Grand Ballroom Foyer | ||
10:15 a.m. - 11:45 a.m. |
Concurrent Oral Presentations III |
|
||
Epidemiology and Global Health |
Salon AB |
|||
10:15 a.m. - 10:30 a.m. |
O-087: Associations of Maternal Urinary Bisphenol and Phthalate Urine Concentrations in Pregnancy with Offspring Pubertal Development |
|
||
10:30 a.m. - 10:45 a.m. |
O-088: Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk |
|
||
10:45 a.m. - 11:00 a.m. |
O-089: Maternal Preconception Platelet Activation and Pregnancy Outcomes |
|
||
11:00 a.m. - 11:15 a.m. |
O-090: The Association between Living in a Food Desert and the Likelihood of Initiating Breastfeeding |
|
||
11:15 a.m. - 11:30 a.m. |
O-091: How Late Is Too Late to Reverse the Effects of the Developmental Origins of Health and Disease? |
|
||
11:30 a.m. - 11:45 a.m. |
O-092: Predictors of Teenage Pregnancy in Zambia between 2007 and 2018 |
|
||
Developmental Programming II |
Salon CD |
|||
10:15 a.m. - 10:30 a.m. |
O-093: Maternal Exposure to Δ9-Tetrahydrocannabinol Results in Symmetrical IUGR Associated with Cardiac Dysfunction in Postnatal Life |
|
||
10:30 a.m. - 10:45 a.m. |
O-094: Under-Expression of Placental Endocrine-Specific Igf2 Programmes Cardiovascular Disease in the Adult Male Offspring |
|
||
10:45 a.m. - 11:00 a.m. |
O-095: Accumulation of Suboptimal Periconceptional Social, Lifestyle and Medical Exposures as Markers for the Maternal Vulnerable Condition and Impairment of Embryonic Growth: The Rotterdam Periconceptional Cohort (Predict Study) |
|
||
11:00 a.m. - 11:15 a.m. |
O-096: Maladaptive Cardiomyocyte Calcium Handling in Adult Offspring of Hypoxic Pregnancy: Protection by Antenatal Maternal Melatonin |
|
||
11:15 a.m. - 11:30 a.m. |
O-097: Vascular Disorders of Pregnancy Increase Susceptibility to Neonatal and Infantile Pulmonary Hypertension in High-Altitude Populations |
|
||
11:30 a.m. - 11:45 a.m. |
O-098: Reduced TGFβ Responsiveness in Skeletal Muscle Satellite Cells from Lambs with Fetal Growth Restriction |
|
||
Reproductive Biology II |
Salon HI |
|||
10:15 a.m. - 10:30 a.m. |
O-099: Polycomb Repressive Complex 2 Antagonizes Wound Healing Responses in the Decidual Stroma by Modulating the Transforming Growth Factor Beta Pathway |
|||
10:30 a.m. - 10:45 a.m. |
O-100: Proteomic Analysis of Extracellular Vesicles Secreted by Primary Endometrial Epithelial Cells from Fertile Women Reveals Functions Related to Embryo Implantation Not Present in an Endometrial Epithelial Cell Line |
|||
10:45 a.m. - 11:00 a.m. |
O-101: Jagged1 Regulates Endometrial Receptivity in Both Humans and Mice |
|||
11:00 a.m. - 11:15 a.m. |
O-102: Antiphospholipid Antibodies Accelerate Endometrial Stromal Cell Decidualization and Senescence and Induce Inflammation via TLR4, p38 MAPK and ROS Signaling |
|||
11:15 a.m. - 11:30 a.m.. |
O-103: The Long-Term Impact of Selective Progesterone Receptor Modulator (SPRM) Ulipristal Acetate (UPA) on the Cell Cycle and Cell Proliferation in Human Endometrium as Assessed by RNA Sequencing |
|||
11:30 a.m. - 11:45 a.m. |
O-104: Next Generation of Human Endometrial Organoids: Bioengineering-Based Strategies for Preserving Tissue-Specific Extracellular Environment |
|||
Placenta II |
Salon KJ |
|||
10:15 a.m. - 10:30 a.m. |
O-105: Fibronectin-Integrin Interactions Regulate Placental Endothelial Cell Migration in Severe Fetal Growth Restriction |
|||
10:30 a.m. - 10:45 a.m. |
O-106: Characterization of Regulation of NLRP3 Inflammasome Activity in Placental Hofbauer Cells |
|||
10:45 a.m. - 11:00 a.m. |
O-107: AKT Signaling Controls Trophoblast Development and Placentation |
|||
11:00 a.m. - 11:15 a.m. |
O-108: Changes in Lipid Profiles of Placental Exosomes in Maternal Plasma Characterize Pregnancies with a Small-for-Gestational Age Fetus |
|||
11:15 a.m. - 11:30 a.m. |
O-109: Velocity-Selective Arterial Spin Labeling Perfusion Measurements in 2nd Trimester Human Placenta |
|||
11:30 a.m. - 11:45 a.m. |
O-110: Placental NRF2 May Serve a Key Role in Maternal-Fetal Tolerance during Pregnancy |
|||
Reproductive Endocrinology and Infertility II |
Wellesley |
|||
10:15 a.m. - 10:30 a.m. |
O-111: Premenstrual Dysphoric Disorder (PMDD) Is Associated with Estradiol-Dependent Aberrations in Cellular Ca2+ Homeostasis and the Endoplasmic Reticulum Stress Response |
|||
10:30 a.m. - 10:45 a.m. |
O-112: Examination of Androgen Effects on Female Reproductive Axis: Hypothalamus-Pituitary-Ovary |
|||
10:45 a.m. - 11:00 a.m. |
O-113: Disparities in Seeking Infertility Care: Data from the 2017-2019 CDC National Survey of Family Growth |
|||
11:00 a.m. - 11:15 a.m. |
O-114: Normal Weight Women with Polycystic Ovary Syndrome (PCOS) Exhibit Oxidative Stress in Response to Saturated Fat Ingestion Even in the Absence of Abdominal Adiposity (AA) |
|||
11:15 a.m. - 11:30 a.m. |
|
|||
11:30 a.m. - 11:45 a.m. |
O-158: Dysregulation of Primordial Follicle Growth Activation Regulatory Factor Expression in a Granulosa Cell Model of Galactosemic Primary Ovarian Insufficiency |
|||
Clinical and Translational Perinatology II |
Suffolk |
|||
10:15 a.m. - 10:30 a.m. |
O-115: Preferred Timing of Efficacy of a New Therapeutic Candidate, Rytvela, for Prevention of Inflammation-Induced Preterm Birth and Fetal Growth Restriction |
|||
10:30 a.m. - 10:45 a.m. |
O-116: Comparative Adverse Effects of Antenatal Glucocorticoid Formulations: Studies in the Chicken Embryo |
|||
10:45 a.m. - 11:00 a.m. |
O-117: Maternal Leukocyte DNA Methylation during Asymptomatic Pregnancy and Future Spontaneous Preterm Birth among Black American Women |
|||
11:00 a.m. - 11:15 a.m. |
O-118: Impact of Progesterone on Mechanism of Preterm Premature Rupture of Membrane |
|||
11:15 a.m. - 11:30 a.m. |
O-119: A Novel Murine Model of Cytomegalovirus Infection in Pregnancy |
|||
11:30 a.m. - 11:45 a.m. |
O-120: Psychological Distress during Pregnancy and Adverse Maternal and Perinatal Health Outcomes; the Role of Socioeconomic Status |
|||
12:00 p.m. - 1:00 p.m. |
Diversity, Equity and Inclusion Forum |
Salon AB |
||
Moderator: |
||||
How to Create an Environment Supportive of Diversity, Equity and Inclusion |
||||
12:00 p.m. - 1:00 p.m. |
Lunch and Learn Symposium III |
|||
Don't Get Lost in Translation: Importance of In Vivo and In Vitro Model Validation |
Salon CD |
|||
12:00 p.m. - 12:25 p.m. |
Back-Translation of Clinical Endpoints and Model Validation in Preclinical Research (fibroids examples) |
|||
12:25 p.m. - 12:50 p.m. |
Modeling Artificial Ovary |
|||
12:50 p.m. - 1:00 p.m. |
Session Q&A |
|||
12:00 p.m. - 1:00 p.m. |
Lunch and Learn Symposium IV |
|
||
Beyond Surgery: Managing Uterine Fibroids in 2021..and Beyond Supported by Myovant Science / Pfizer |
Salon HI |
|||
12:00 p.m. - 12:15 p.m |
Non-Surgical Interventions for Uterine Fibroids |
|||
12:15 p.m. - 12:30 p.m. |
Non-Hormonal Options for Uterine Fibroids |
|||
12:30 p.m. - 12:45 p.m |
Hormonal Options for Uterine Fibroids |
|||
12:45 p.m. - 1:00 p.m. |
Session Q&A |
|||
1:15 p.m. - 2:45 p.m. |
Concurrent Oral Presentations IV |
|
||
Fetus II |
Salon AB |
|||
1:15 p.m. - 1:30 p.m. |
O-121: MAP4K4: Identification of a Novel Candidate Gene Using Prenatal Exome Sequencing Data and Functional Modeling in Zebrafish |
|
||
1:30 p.m. - 1:45 p.m. |
O-122: An Aberrant Endothelial Cell Response to Flow: Mechanistic Implications for Congenital Heart Defects in the Feto-Placental Unit |
|
||
1:45 p.m. - 2:00 p.m. |
O-123: Measuring In Vivo Arterial Stiffness in Fetal Life |
|
||
2:00 p.m. - 2:15 p.m. |
O-124: In Utero e-Cigarettes Exposure Enhances Neonatal Brain Ischemic Damage: Role of the miRNA-30c |
|
||
2:15 p.m. - 2:30 p.m. |
O-125: Early and Mid-Gestation Zika Virus (Zikv) Infection in the Olive Baboon (Papio anubis) Leads to Neurological Birth Defects Due to Congenital Zika Syndrome (czs) |
|
||
2:30 p.m. - 2:45 p.m. |
O-126: Thyroid Hormone Dominates IGF1 Expression and Actions in Fetal Cardiomyocytes |
|
||
Health Disparities and COVID |
Salon CD |
|||
1:15 p.m. - 1:30 p.m. |
O-127: Black and White Women in the United States Military Have Comparable Rates of Preeclampsia and Post-Preeclamptic Cardiovascular Disease |
|
||
1:30 p.m. - 1:45 p.m. |
O-128: Racial and Ethnic Disparities in Complications among Patients Undergoing a Trial of Labor after Cesarean Section at Mount Sinai Hospital |
|
||
1:45 p.m. - 2:00 p.m. |
O-129: Potential Risk of Infection of First Trimester Placentas by SARS-CoV2 |
|
||
2:00 p.m. - 2:15 p.m. |
O-130: Impact of SARS-CoV-2 Infection during Pregnancy by Maternal Race-Ethnicity |
|
||
2:15 p.m. - 2:30 p.m. |
O-131: Stressors in Fertility Treatment: The Impact of the COVID-19 Pandemic |
|
||
2:30 p.m. - 2:45 p.m. |
O-132: Expression of SARS-CoV-2 Entry Molecules at Maternal-Fetal Interface and Regulation of Proinflammatory Cytokines and Coagulation Factor III in Human Placental Microvascular Endothelial Cell by Spike Protein |
|
||
Placenta III |
Salon HI |
|||
1:15 p.m. - 1:30 p.m. |
O-133: Chorionic Somatomammotropin RNA Interference Reduces Global Nutrient Uptake and Umbilical Blood Flow Resulting in Intrauterine Growth Restriction |
|||
1:30 p.m. - 1:45 p.m. |
O-134: Trophoblast-Specific Knockdown of the System A Amino Acid Transporter, Slc38a2/SNAT2, Causes Fetal Growth Restriction in Mice |
|||
1:45 p.m. - 2:00 p.m. |
O-135: An In Vitro Placenta Model with a Native Stroma for Mechanistic Transport Studies |
|||
2:00 p.m. - 2:15 p.m. |
O-136: Obesity Downregulates Lipid Metabolism Genes in First Trimester Placenta |
|||
2:15 p.m. - 2:30 p.m. |
O-159: A Multiomics Approach To Placental Dysfunction In Common |
|||
2:30 p.m. - 2:45 p.m. |
O-160: Determining the Impact of Environmental Toxin Cadmium at the Feto- |
|||
Reproductive Biology III |
Salon KJ | |||
1:15 p.m. - 1:30 p.m. |
O-137: Thymic Progesterone Receptor Expression Regulates Maternal Thymic Involution in Murine Pregnancy |
|||
1:30 p.m. - 1:45 p.m. |
O-138: A Role for the IL-33-ILC2 Axis in Driving Uterus-Intrinsic Parturition Pathways in Mice |
|||
1:45 p.m. - 2:00 p.m. |
O-139: Single-Cell RNA Sequencing Identifies Novel Uterine Macrophage Population Increased by Regulatory T Cells and Associated with Decreased Fetal Loss |
|||
2:00 p.m. - 2:15 p.m. |
O-140: Pluripotent Stem Cell Derived Endometrial Stromal Fibroblasts Co-Culture with Endometrial Epithelial Organoids to Form a 3-Dimensional Model of the Human Endometrium |
|||
2:15 p.m. - 2:30 p.m. |
O-141: The Vertical Transfer of Maternal Immune Cells during Pregnancy Promotes Neonatal Immunity against Viral Infections in Mice |
|||
2:30 p.m. - 2:45 p.m. |
O-142: Differentiation of Mouse iPSCs into Functional Oocytes |
|||
Preeclampsia II |
Wellesley |
|||
1:15 p.m. - 1:30 p.m. |
O-143: HO-1 Genetic Variants Display Racial Diversity and May Impact Hypertensive Disorders in Pregnancy |
|||
1:30 p.m. - 1:45 p.m. |
O-144: Surgically Increasing Uteroplacental Impedance Results in Attenuated Uterine Vascular Remodeling and Preeclampsia-Related Placental Secretomics during Pregnancy |
|||
1:45 p.m. - 2:00 p.m. |
O-145: The New Generation Antiplatelet Agent Prasugrel Represents an Exciting Novel Candidate Therapy for Preeclampsia |
|||
2:00 p.m. - 2:15 p.m. |
O-146: Sildenafil Improves Placental Function and Remodeling in Preeclamptic Rats |
|||
2:15 p.m. - 2:30 p.m. |
O-147: Differential Distribution of Tryptophan-Metabolites in Fetal and Maternal Circulations during Pregnancy: Preeclampsia-Elevated Aryl Hydrocarbon Receptor Ligands |
|||
2:30 p.m. - 2:45 p.m. |
O-148: Can WS1442 Ameliorate Maternal Vascular Dysfunction in Preeclampsia? |
|||
Gynecology Oncology |
Suffolk |
|||
1:15 p.m. - 1:30 p.m. |
O-149: Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma |
|||
1:30 p.m. - 1:45 p.m. |
O-150: Endoplasmic Reticulum Stress Response to Hyperinsulinemia in Endometrial Epithelial Cells Depends on PIK3CA Mutation |
|||
1:45 p.m. - 2:00 p.m. |
O-151: ACS NSQIP - Personalised Risk Prediction Tool for Postoperative Complications in Gynaeoncology Surgery? |
|||
2:00 p.m. - 2:15 p.m. |
O-152: High NLRP7 Expression Promotes Choriocarcinoma Development: Proof |
|||
2:15 p.m. - 2:30 p.m. |
O-161: Entinostat Increases Sensitivity to Olaparib in a Homologous |
|||
2:30 p.m. - 2:45 p.m. |
O-162: Factors Associated with Referral-Based Receipt of Fertility |
|||
2:45 p.m. - 4:15 p.m. |
Poster Session II |
Back Bay Conference and Exhibition Center |
||
4:15 p.m. - 6:15 p.m. |
Mini Symposia II |
|
||
SRI – SSR Joint Session: Immune Cell Regulation of Implantation/Pregnancy |
Salon AB |
|||
4:15 p.m. - 4:40 p.m. |
Neutrophils at the Maternal-Fetal Interface: Friend or Foe? |
|||
4:40 p.m. - 5:05 p.m. |
The Stage Is Set Before the Play Commences – Maternal Immunological Detection of the Conceptus |
|||
5:05 p.m. - 5:30 p.m. |
Maternal Immunity and Tolerance During Pregnancy |
|||
5:30 p.m. - 5:55 p.m. |
Fetal-Maternal Disagreement: Immune Responses in Placental Villitis |
|||
5:55 p.m. - 6:15 p.m. |
Session Q&A |
|||
Update on Diagnostics and Therapeutics for Preterm Birth |
Suffolk |
|||
4:15 p.m. - 4:25 p.m. |
Overview of the Pathway to Preterm Birth |
|||
4:25 p.m. - 4:45 p.m. |
Leukocyte Migration as a Diagnostic for Delivery |
|||
4:45 p.m. - 5:10 p.m. |
New and Emerging Biomarker Prediction Tests for Preterm Birth |
|||
5:10 p.m. - 5:35 p.m. |
Development of Novel Therapeutics to Counter Preterm Birth |
|||
5:35 p.m. - 6:00 p.m. |
Pharmaceutical industry development in preterm labor treatment: current landscape |
|||
6:00 p.m. - 6:15 p.m. |
Session Q&A |
|||
Drivers and Therapeutic Targets for Gynecologic Cancers Associated with Benign Gynecologic Conditions |
Salon CD |
|||
4:15 p.m. - 4:40 p.m. |
ARID1A as a Driver and Target for Therapy for Endometriosis-Associated Ovarian Cancer (Implications for Immunotherapy) |
|||
4:40 p.m. - 5:05 p.m. |
Toxicant Exposure, Endocrine Disruptors and Adenomyosis (Environmental Influence) |
|||
5:05 p.m. - 5:30 p.m. |
The Insulin/Insulin Growth Factor and Sex Hormone Axes in the Normal Endometrium and in Tumor Microenvironment of Endometrial Cancer (Environmental Influence of Obesity and Implications for Immunotherapy) |
|||
5:30 p.m. - 5:55 p.m. |
Mouse Models of Endometriosis-Associated Gynecologic Cancers |
|||
5:55 p.m. - 6:15 p.m. |
Session Q&A |
|||
Antenatal Steroid Therapy Optimisation. From Clinic to Bench and Back Again |
Wellesley |
|||
4:15 p.m. - 4:40 p.m. |
When, What and How Often? Revisiting the Scientific Basis of Antenatal Steroid Therapy |
|||
4:40 p.m. - 5:05 p.m. |
Hunting for Goldilocks - Efforts Past and Present to get Antenatal Steroid Dosing Just Right |
|||
5:05 p.m. - 5:30 p.m. |
Optimisation of Antenatal Steroids for Low and Middle Income Countries |
|||
5:30 p.m. - 5:55 p.m. |
Short & Long Term Benefits & Risks of Multiple Courses of Antenatal Corticosteroids |
|||
5:55 p.m. - 6:15 p.m. |
Session Q&A |
|||
Role of miRNA’s and Inflammation in the Pathology of Endometriosis |
Salon KJ |
|||
4:15 p.m. - 4:40 p.m.. |
Insights Into Contributions of Stem Cell and Inflammatory Pathways in the Pathophysiology of Endometriosis |
|||
4:40 p.m. - 5:05 p.m.. |
Macrophages in the Pathophysiology of Endometriosis: Mouse Models As Tools for Clinical Translation |
|||
5:05 p.m. - 5:30 p.m. |
miRNA’s in Endometriosis: Pathological Insights and Clinical Implications From a Baboon Model |
|||
5:30 p.m. - 5:55 p.m. |
miRNA’s in Endometriosis: Diagnostic Potential and Pathophysiology in Women With Disease |
|||
5:55 p.m. - 6:15 p.m. |
Session Q&A |
|||
An Update on the Impact of COVID-19 on Maternal-Child Health, |
Salon HI | |||
4:15 p.m. - 4:40 p.m. |
HIGHLY PATHOGENIC RESPIRATORY VIRUS INFECTIONS IN PREGNANCY: |
|||
4:40 p.m. - 5:05 p.m. |
Risks to the fetus of maternal COVID-19, an evidence-based analysis |
|||
5:05 p.m. - 5:30 p.m. |
Placental changes in response to infection and vaccination |
|||
5:30 p.m. - 5:55 p.m. |
What COVID-19 may mean to the developmental origins of health and disease |
|||
5:55 p.m. - 6:15 p.m. |
Session Q&A |
9:00 a.m. - 1:00 p.m. |
Career Development Workshops |
Virtual |
||
1:30 p.m. - 2:30 p.m. |
Your Grant in One Page Clinic |
Virtual |